You searched for "OME"
Hearing difficulties and memory problems
Since the Lancet Commission report in 2020, we have all been aware that untreated hearing loss is potentially one of the biggest modifiable risk factors for dementia in midlife. Hearing loss is also associated with other risk factors for dementia,...
Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL
Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...
Outcomes of office-based biopsies for laryngopharyngeal carcinoma – faster diagnoses and equivalent oncological outcomes as compared to biopsies under general anaesthesia
Patients in the UK with head and neck cancers are the most likely to face long waits to treatment in comparison to other cancer sites, with only just over half commencing treatment within 62 days of being referred on a...
Audiometric and Quality of Life comparison between Bonebridge® and Osia®
Bone conduction implants are an alternative to hearing aids for varying reasons. Both Bonebridge® and Osia® are transcutaneous devices maintaining intact skin, establishing a connection between the implanted device and external processor through a magnetic system. Both are described as...
Case study suggesting mtDNA mutation as a tinnitus factor: ND1:m.3394T>C
Konadath et al report a genetic case study of a 24-year-old female experiencing reduced hearing sensitivity and tinnitus along with a blocked sensation in her right ear, sudden onset one year prior with no other otological complaints. Standard audiometry along...
Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?
Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...
